Picture of Agilent Technologies logo

A Agilent Technologies Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Momentum

Relative Strength (%)
1m-10.76%
3m-20.36%
6m-18.2%
1yr-28.38%
Volume Change (%)
10d/3m+54.89%
Price vs... (%)
52w High-34.03%
50d MA-16.19%
200d MA-23.69%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)17.63
PEG Ratio (f)1.54
EPS Growth (f)12.92%
Dividend Yield (f)0.99%
Valuation (ttm)IndustryMarket
Price to Book Value4.85
Price to Tang. Book26.95
Price to Free Cashflow22.27
Price to Sales4.47
EV to EBITDA17.67

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital14.87%
Return on Equity20.61%
Operating Margin22.87%

Financial Summary

Year End 31st OctUnit202020212022202320242025E2026ECAGR / Avg
Total Revenue$m5,3396,3196,8486,8336,5106,740.77,148.974.75%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%-18.3+42.62+4.16+19.99-9.13+16.59+9.31n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Oct 202531st Oct 2026
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2025 / 2026

Blurred out image of Agilent Technologies EPS forecast chart

Profile Summary

Agilent Technologies, Inc. is engaged in providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company’s life sciences and applied markets segment provides application-focused solutions that include instruments, consumables and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. Its diagnostics and genomics segment includes the cell analysis, advanced manufacturing partnerships contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, genomics and biomolecular analysis businesses. The Agilent CrossLab segment offers a service portfolio that includes repairs, parts, maintenance, installations and various other custom services to support the laboratory operations. It also offers contract development and manufacturing organization (CDMO) services.

Directors

Last Annual
October 31st, 2024
Last Interim
January 31st, 2025
Incorporated
May 4th, 1999
Public Since
November 18th, 1999
No. of Shareholders
16,806
No. of Employees
17,900
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
us flag iconNew York Stock Exchange
Shares in Issue
285,102,717

A Share Price Performance

Latest News for A

Upcoming Events for A

Q2 2025 Agilent Technologies Inc Earnings Release

Q2 2025 Agilent Technologies Inc Earnings Call

Q3 2025 Agilent Technologies Inc Earnings Release

Similar to A

Picture of Abbott Laboratories logo

Abbott Laboratories

us flag iconNew York Stock Exchange

Picture of Alcon AG logo

Alcon AG

us flag iconNew York Stock Exchange

Picture of Artivion logo

Artivion

us flag iconNew York Stock Exchange

Picture of Avanos Medical logo

Avanos Medical

us flag iconNew York Stock Exchange

Picture of Avantor logo

Avantor

us flag iconNew York Stock Exchange

FAQ